Skip to main content
Log in

Delayed logistic indirect response models: realization of oscillating behavior

  • Original Paper
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

Indirect response (IDR) models are probably the most frequently applied tools relating the effect of a signal to a baseline response. A response modeled by such a classical IDR model will always return monotonously to its baseline after drug administration. We extend IDR models with a delay process, i.e. a retarded response state, that leads to oscillating response behavior. First, IDR models with a first-order production and second-order loss term based on the famous logistic equation are constructed. Second, a delay process similar to the delayed logistic equation is included. Relations of the classical IDR model with our extended IDR model concerning response and model parameters are revealed. Simulations of typical response profiles are presented and data fitting of a model for leptin and cholesterol dynamics after administration of methylprednisolone is performed. The influence of the delay parameter on the other model parameters is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dayneka NL, Garg V, Jusko WJ (1993) Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21(4):457–78

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Koch G, Schropp J (2013) Mathematical concepts in pharmacokinetics and pharmacodynamics with application to tumor growth. In: Kloeden PE, Poetzsche C (eds) Nonautonomous dynamical systems in the life sciences. Springer, Berlin

    Google Scholar 

  3. Sharma A, Ebling WF, Jusko WJ (1998) Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena. J Pharm Sci 87(12):1577–84

    Article  CAS  PubMed  Google Scholar 

  4. Gabrielsson J, Peletier LA (2007) A nonlinear feedback model capturing different patterns of tolerance and rebound. Eur J Pharm Sci 32(2):85–104

    Article  CAS  PubMed  Google Scholar 

  5. Zuideveld KP, Maas J, Treijtel N, Hulshof J, van der Graaf PH, Peletier LA, Danhof M (2001) A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia. Am J Physiol Regulatory Integr Comp Physiol 281:R2059–R2071

    Article  CAS  Google Scholar 

  6. Zhang Y, D’Argenio DZ (2016) Feedback control indirect response models. J Pharmacokinet Pharmacodyn 43(4):343–58

    Article  PubMed  Google Scholar 

  7. Chakraborty A, Krzyzanski W, Jusko WJ (1999) Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinet Biopharm 27(1):23–43

    Article  CAS  PubMed  Google Scholar 

  8. Verotta D (2010) Fractional dynamics pharmacokinetics-pharmacodynamic models. J Pharmacokinet Pharmacodyn 37(3):257–76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liz E (2014) Delayed logistic population models revisited. Publ Mat 2014:309–31

    Article  Google Scholar 

  10. Hadeler KP, Bocharov G (2003) Where to put delays in population models, in particular in the neutral case. Can Appl Math Q 11:159–73

    Google Scholar 

  11. Krzyzanski W, Ramakrishan R, Jusko WJ (1999) Basic pharmacodynamic models for agents that alter production of natural cells. J Pharmacokinet Biopharm 27:467–89

    Article  CAS  PubMed  Google Scholar 

  12. Krzyzanski W, Perez-Ruixo JJ (2012) Lifespan based indirect response models. J Pharmacokinet Pharmacodyn 39:109–23

    Article  PubMed  PubMed Central  Google Scholar 

  13. Krzyzanski W, Jusko WJ, Wacholtz MC, Minton N, Cheung WK (2005) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects. Eur J Pharm Sci 26:295–306

    Article  CAS  PubMed  Google Scholar 

  14. Perez-Ruixo JJ, Krzyzanski W, Bouman-Thio E, Miller B, Jang H, Bai SA, Zhou H, Yohrling J, Cohen A, Burggraaf J, Franson K, Davis HM (2009) Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects. Clin Pharmacokinet 48:601–13

    Article  CAS  PubMed  Google Scholar 

  15. Verhulst PF (1838) Notice sur la loi que la population suit dans son accroissement. Correspondance mathématique et physique 10:113–21

    Google Scholar 

  16. Hutchinson GE (1948) Circular causal systems in ecology. Ann New York Acad Sci 50:221–46

    Article  CAS  Google Scholar 

  17. Smith H (2010) An introduction to delay differential equations with applications to the life sciences. Texts in Applied Mathematics. Springer, Berlin

    Google Scholar 

  18. Koch G, Krzyzanski W, Perez-Ruixo JJ, Schropp J (2014) Modeling of delays in PKPD: classical approaches and a tutorial for delay differential equations. J Pharmacokinet Pharmacodyn 41(4):291–318

    Article  PubMed  Google Scholar 

  19. Arino J, Wang L, Wolkowicz GSK (2006) An alternative formulation for a delayed logistic equation. J Theor Biol 241:109–19

    Article  PubMed  Google Scholar 

  20. Sukumaran S, Jusko WJ, DuBois DC, Almon RR (2011) Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression. J Pharmacol Exp Ther 337(3):734–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hazra A, Pyszczynski NA, DuBois DC, Almon RR, Jusko WJ (2008) Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats. Pharm Res 25(4):769–80

    Article  CAS  PubMed  Google Scholar 

  22. Hairer E, Nørsett SP, Wanner G (1993) Solving ordinary differential equations I. Springer Series in Computational Mathematics, vol 8, 2nd edn. Springer, New York

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gilbert Koch.

Appendices

Appendix 1: Computation of the PD effect \(PD_{eff}\)

We have introduced the classical IDR model and the logistic equation based LoIDR and DLoIDR models. Depending on the action of the drug we have four different realizations \(f=f_i\), \(i=I,II,III,IV\) for each model. We now show the proposed PD effect \(PD_{eff}\) for these models only when the drug inhibits the inflow term, i.e., \(f=f_{I}\). A slightly modified proof also works for the three other realizations. In case of \(f=f_{I}\) we have to calculate

$$\begin{aligned} PD_{eff}&= \int _0^{\infty } R_{Base} -R(t) \, dt \end{aligned}$$

with \(R_{Base}=R^0\) for the classical IDR model and \(R_{Base}=R^0_L\) in case of the LoIDR and DLoIDR model.

  1. (i)

    IDR model PD effect:

Using Eq. (11) we obtain

$$\begin{aligned} PD_{eff}= \, & {} \frac{1}{k_{out}} \int _0^{\infty } k_{in} -k_{out} R(t) \, dt \\= \, & {} \frac{1}{k_{out}} \int _0^{\infty } \frac{d}{dt} R(t) + k_{in} e(c(t)) \,dt \end{aligned}$$
(18)
$$\begin{aligned}= \, & {} \frac{1}{k_{out}} \int _0^{\infty } \frac{d}{dt} R(t) \, dt \; + \int _0^{\infty } R^0 e(c(t)) \, dt . \end{aligned}$$
(19)

Due to \(R^0 = R(0) = \lim _{t \rightarrow \infty } R(t)\) the left integral on the right hand side of Eq. (19) vanishes and we end up with

$$\begin{aligned} PD_{eff}&= \int _0^{\infty } R^0 e(c(t)) \, dt . \end{aligned}$$
(20)
  1. (ii)

    LoIDR model PD effect:

With the model Eq. (14) we can calculate

$$\begin{aligned} PD_{eff}= \, & {} \int _0^{\infty } R^0_L - R(t) \, dt \\= \, & {} \int _0^{\infty } \frac{1}{k_{outL} R(t)} \frac{d}{dt} R(t)+ R^0_L e(c(t))\,dt \end{aligned}$$
(21)
$$\begin{aligned}= \, & {} \int _0^{\infty } \frac{1}{k_{outL}} \frac{d}{dt} ({\text{ ln }}(R(t))) \, dt \\&+ \int _0^{\infty } R^0_L e(c(t)) \, dt \\= \, & {} \frac{1}{k_{outL}} \lim _{b \rightarrow \infty } \left[ {\text{ ln }}(R(t)) \right] _{t=0}^{t=b} \\&+ \int _0^{\infty } R^0_L e(c(t)) \, dt \, . \end{aligned}$$
(22)

Again, using \(R^0_L = R(0) = \lim _{t \rightarrow \infty } R(t)\) the first term on the right hand side of Eq. (22) vanishes and we end up with the proposed result Eq. (20).

  1. (iii)

    DLoIDR model PD effect:

In presence of a delay we use the initial condition \(R(s) =R^0_L\), \( -T \le s \le 0\) and rewrite the PD effect term to

$$\begin{aligned} PD_{eff}= \, & {} \int _0^{\infty } R^0_L -R(t) \, dt \\= \, & {} \int _T^{\infty } R^0_L -R(t-T) \, dt \\= \, & {} \int _0^{\infty } R^0_L -R(t-T) \, dt \, . \end{aligned}$$
(23)

We use the representation Eq. (23) of the PD effect as well as Eq. (16) and compute

$$\begin{aligned} PD_{eff}= \, & {} \int _0^{\infty } R^0_L - R(t-T) \, dt \\= \, & {} \int _0^{\infty } \frac{1}{k_{outL} R(t)} \frac{d}{dt} R(t)+ R^0_L e(c(t)) \, dt \, . \end{aligned}$$
(24)

The Eq. (24) and Eq. (21) are identical and we can mimic the computation of part (ii) and obtain the final result Eq. (20).

Appendix 2: Stability of the equilibria \(R^0\) and \(R^0_L\)

The base equations (\(c=0\)) to the proposed models read

$$\begin{aligned} \frac{d}{dt} R(t)&= k_{in} -k_{out} R(t) \end{aligned}$$
(25)

for Eqs. (11)–(12),

$$\begin{aligned} \frac{d}{dt} R(t)&=k_{inL} R(t) -k_{outL}R(t) R(t-T) \end{aligned}$$
(26)

for Eqs. (14)–(15) (\(T=0\)) and Eqs. (16)–(17) (\(T>0\)).

Linearizing Eqs. (25)–(26) at their baseline \(R^0\), \(R^0_L\) respectively, leads to

$$\begin{aligned} \frac{d}{dt} h(t)&= -k_ {out} h(t) \end{aligned}$$
(27)

for the IDR model, and

$$\begin{aligned} \frac{d}{dt} h(t)&= - k_{inL} h(t-T) \end{aligned}$$
(28)

for the LoIDR (\(T =0\)) and the DLoIDR Eqs. (\(T >0\)). Thus, the equilibria \(R^0\), \(R^0_L\) are stable for the IDR and the LoIDR model. Moreover, due to Hairer et al. [22] the baseline \(R^0_L\) is stable for the DLoIDR model if \(0< T < \pi /(2 k_{inL})\). Finally, comparing Eq. (27) with Eq. (28) (\(T=0\)) shows that the solutions R(t) of the classical IDR and the LoIDR model approximate the equilibria with the same exponential rate, if \(R^0 =R^0_L\) and \(k_{out} = k_{inL}\) holds.

Appendix 3: Linearized LoIDR model

Linearizing the LoIDR model Eq. (14) of type I, III at its baseline \(\bar{R} = R_L^0 = k_{inL}/k_{outL}\), \(\bar{c} = 0\) yields

$$\begin{aligned} \frac{d}{dt} h(t)= \, & {} \left( f_{I,III}(\Theta _L, 0, R^0_L) + R^0_L \frac{\partial f_{I,III}}{\partial R}( \Theta _L,0, R^0_L)\right) \\&\cdot (h(t)-R^0_L )\\= \, & {} - R^0_L k_{outL} (h(t)-R^0_L )\\= \, & {} - k_{inL}h(t)+ k_{inL} R^0_L , \end{aligned}$$

which is the IDR model at \(\bar{c} =0\) with production rate \(k_{in} = k_{inL} R^0_L\) and loss rate \(k_{out}= k_{inL}\). Finally, a similar argument holds for type II, IV.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Koch, G., Schropp, J. Delayed logistic indirect response models: realization of oscillating behavior. J Pharmacokinet Pharmacodyn 45, 49–58 (2018). https://doi.org/10.1007/s10928-017-9563-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-017-9563-8

Keywords

Navigation